Terumo Aortic Global Endovascular Registry for Aortic Aneurysms

This study, called the Terumo Aortic Global Endovascular Registry, is looking at how well different Terumo Aortic stent grafts work in real-world use. These grafts include the Relay stent graft system (for the chest), Anaconda or Treo Stent graft systems (for the abdomen), and custom devices like Fenestrated Anaconda or Fenestrated TREO. You might be able to join if you are at least 18 years old, need a repair for an aortic aneurysm (a bulge in your main artery), and are getting one of these Terumo Aortic grafts. The main goal is to see how many people experience aortic-related death within 30 days after getting the implant. The study is currently unclear on its recruitment status and aims to enroll 1000 participants.

Study design
This is an observational registry, meaning researchers will collect information from your standard medical care. It is open-label, so both you and your doctors will know what treatment you are receiving. The study aims to enroll 1000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint measures aortic-related mortality at 30 days post implant. The overall follow-up duration is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04246463

Terumo Aortic Global Endovascular Registry

Recruiting
Not specifiedAges 18+Observational
Vascutek Ltd.
~1,000 participants
Updated 2026-03-13 on ClinicalTrials.gov
What's tested:ThoracicAbdominalCustom DeviceIlliac Artery

At a glance

Recruiting sites
50 of 58 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Aortic Related Mortality
Measured over 30 days post implant
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Surgery
58 sites across 22 states
Italy9
Germany8
Netherlands7
Spain4
United Kingdom4
Portugal3
Colorado2
Pennsylvania2

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Minimum age as per local regulations
Indication for aortic endovascular repair with an approved or CE marked by a Regulatory body or custom-made Terumo Aortic Endovascular graft
Ability to provide informed consent
Willingness to comply with the registry protocol
Willingness to adhere to follow-up visits Note: Patients currently enrolled and actively participating within the TREO registry (IP-0020-16) can have their data migrated from TREO to the TiGER registry where local EC approval has been obtained and the patient has been reconsented to TiGER for longer follow-up.
  • Aortic Related Mortality30 days post implant

    Defined as any death occurring within 30 days of implant, due to rupture or following any procedure intended to treat the target lesion